Fowler John Franklin — SEC Form 4 filings

SEC reporting owner CIK 1744263. 3 Form 4 filings on record with FilingPulse; latest filed 2026-05-11.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-02-14 to 2026-05-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kezar Life Sciences, Inc. (KZR)Director316

Form 4 filings — Fowler John Franklin

FiledFormIssuerReported transactionsSource
2026-05-114Kezar Life Sciences, Inc. (KZR)Code (U): 39,390 · Code (U): 375 · Code (U): 3,846 · Disposition to issuer (D): 4,893 (derivative) @ $0 · Disposition to issuer (D): 17,792 (derivative) @ $0 · Disposition to issuer (D): 8,896 (derivative) @ $0 · +8 moreEDGAR
2025-06-234Kezar Life Sciences, Inc. (KZR)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2025-02-144Kezar Life Sciences, Inc. (KZR)Grant/award (A): 5,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1744263 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →